nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—Eye irritation—Lovastatin—atherosclerosis	0.0136	0.0311	CcSEcCtD
Carbachol—Tenderness—Lovastatin—atherosclerosis	0.0133	0.0304	CcSEcCtD
Carbachol—Necrosis—Niacin—atherosclerosis	0.0127	0.0291	CcSEcCtD
Carbachol—Tenderness—Simvastatin—atherosclerosis	0.0124	0.0285	CcSEcCtD
Carbachol—Tenderness—Pravastatin—atherosclerosis	0.0112	0.0257	CcSEcCtD
Carbachol—Cramp muscle—Lovastatin—atherosclerosis	0.00757	0.0174	CcSEcCtD
Carbachol—Cramp muscle—Ezetimibe—atherosclerosis	0.00742	0.017	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00722	0.0166	CcSEcCtD
Carbachol—Cramp muscle—Simvastatin—atherosclerosis	0.00708	0.0162	CcSEcCtD
Carbachol—Abdominal discomfort—Lovastatin—atherosclerosis	0.00696	0.016	CcSEcCtD
Carbachol—Abdominal discomfort—Simvastatin—atherosclerosis	0.00651	0.0149	CcSEcCtD
Carbachol—Cramp muscle—Pravastatin—atherosclerosis	0.0064	0.0147	CcSEcCtD
Carbachol—Arrhythmia—Rosuvastatin—atherosclerosis	0.00613	0.0141	CcSEcCtD
Carbachol—Sweating increased—Pravastatin—atherosclerosis	0.00598	0.0137	CcSEcCtD
Carbachol—Flatulence—Rosuvastatin—atherosclerosis	0.00588	0.0135	CcSEcCtD
Carbachol—Flushing—Lovastatin—atherosclerosis	0.00539	0.0124	CcSEcCtD
Carbachol—Sweating—Niacin—atherosclerosis	0.00533	0.0122	CcSEcCtD
Carbachol—Flushing—Ezetimibe—atherosclerosis	0.00529	0.0121	CcSEcCtD
Carbachol—Flushing—Simvastatin—atherosclerosis	0.00505	0.0116	CcSEcCtD
Carbachol—Flatulence—Lovastatin—atherosclerosis	0.00499	0.0114	CcSEcCtD
Carbachol—Flatulence—Ezetimibe—atherosclerosis	0.00489	0.0112	CcSEcCtD
Carbachol—Muscle spasms—Lovastatin—atherosclerosis	0.00486	0.0112	CcSEcCtD
Carbachol—Infection—Rosuvastatin—atherosclerosis	0.00484	0.0111	CcSEcCtD
Carbachol—Muscle spasms—Ezetimibe—atherosclerosis	0.00477	0.0109	CcSEcCtD
Carbachol—Flatulence—Simvastatin—atherosclerosis	0.00466	0.0107	CcSEcCtD
Carbachol—Flushing—Niacin—atherosclerosis	0.00463	0.0106	CcSEcCtD
Carbachol—Flushing—Pravastatin—atherosclerosis	0.00456	0.0105	CcSEcCtD
Carbachol—Muscle spasms—Simvastatin—atherosclerosis	0.00455	0.0104	CcSEcCtD
Carbachol—Arrhythmia—Niacin—atherosclerosis	0.00446	0.0102	CcSEcCtD
Carbachol—Arrhythmia—Pravastatin—atherosclerosis	0.00439	0.0101	CcSEcCtD
Carbachol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00429	0.00984	CcSEcCtD
Carbachol—Flatulence—Niacin—atherosclerosis	0.00428	0.00982	CcSEcCtD
Carbachol—Flatulence—Pravastatin—atherosclerosis	0.00422	0.00967	CcSEcCtD
Carbachol—Muscle spasms—Niacin—atherosclerosis	0.00418	0.00959	CcSEcCtD
Carbachol—Pain—Rosuvastatin—atherosclerosis	0.00417	0.00956	CcSEcCtD
Carbachol—Muscle spasms—Pravastatin—atherosclerosis	0.00411	0.00944	CcSEcCtD
Carbachol—Infection—Lovastatin—atherosclerosis	0.0041	0.00941	CcSEcCtD
Carbachol—Infection—Ezetimibe—atherosclerosis	0.00402	0.00923	CcSEcCtD
Carbachol—Syncope—Niacin—atherosclerosis	0.0039	0.00894	CcSEcCtD
Carbachol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00385	0.00884	CcSEcCtD
Carbachol—Infection—Simvastatin—atherosclerosis	0.00384	0.0088	CcSEcCtD
Carbachol—Loss of consciousness—Niacin—atherosclerosis	0.00382	0.00876	CcSEcCtD
Carbachol—Dyspepsia—Lovastatin—atherosclerosis	0.00363	0.00834	CcSEcCtD
Carbachol—Dyspepsia—Ezetimibe—atherosclerosis	0.00357	0.00818	CcSEcCtD
Carbachol—Pain—Lovastatin—atherosclerosis	0.00353	0.0081	CcSEcCtD
Carbachol—Shock—Niacin—atherosclerosis	0.00349	0.00801	CcSEcCtD
Carbachol—Infection—Pravastatin—atherosclerosis	0.00347	0.00796	CcSEcCtD
Carbachol—Pain—Ezetimibe—atherosclerosis	0.00346	0.00795	CcSEcCtD
Carbachol—Hyperhidrosis—Niacin—atherosclerosis	0.00343	0.00787	CcSEcCtD
Carbachol—Dyspepsia—Simvastatin—atherosclerosis	0.0034	0.0078	CcSEcCtD
Carbachol—Hyperhidrosis—Pravastatin—atherosclerosis	0.00338	0.00775	CcSEcCtD
Carbachol—Diarrhoea—Rosuvastatin—atherosclerosis	0.00333	0.00765	CcSEcCtD
Carbachol—Hypotension—Niacin—atherosclerosis	0.00331	0.0076	CcSEcCtD
Carbachol—Pain—Simvastatin—atherosclerosis	0.0033	0.00758	CcSEcCtD
Carbachol—Abdominal pain—Lovastatin—atherosclerosis	0.00326	0.00749	CcSEcCtD
Carbachol—Body temperature increased—Lovastatin—atherosclerosis	0.00326	0.00749	CcSEcCtD
Carbachol—Dizziness—Rosuvastatin—atherosclerosis	0.00322	0.00739	CcSEcCtD
Carbachol—Abdominal pain—Ezetimibe—atherosclerosis	0.0032	0.00735	CcSEcCtD
Carbachol—Body temperature increased—Ezetimibe—atherosclerosis	0.0032	0.00735	CcSEcCtD
Carbachol—Dyspepsia—Niacin—atherosclerosis	0.00312	0.00716	CcSEcCtD
Carbachol—Dyspepsia—Pravastatin—atherosclerosis	0.00307	0.00705	CcSEcCtD
Carbachol—Rash—Rosuvastatin—atherosclerosis	0.00307	0.00705	CcSEcCtD
Carbachol—Dermatitis—Rosuvastatin—atherosclerosis	0.00307	0.00704	CcSEcCtD
Carbachol—Body temperature increased—Simvastatin—atherosclerosis	0.00305	0.00701	CcSEcCtD
Carbachol—Abdominal pain—Simvastatin—atherosclerosis	0.00305	0.00701	CcSEcCtD
Carbachol—Headache—Rosuvastatin—atherosclerosis	0.00305	0.007	CcSEcCtD
Carbachol—Pain—Niacin—atherosclerosis	0.00303	0.00696	CcSEcCtD
Carbachol—Pain—Pravastatin—atherosclerosis	0.00299	0.00685	CcSEcCtD
Carbachol—Nausea—Rosuvastatin—atherosclerosis	0.00289	0.00664	CcSEcCtD
Carbachol—Diarrhoea—Lovastatin—atherosclerosis	0.00283	0.00648	CcSEcCtD
Carbachol—Abdominal pain—Niacin—atherosclerosis	0.0028	0.00643	CcSEcCtD
Carbachol—Body temperature increased—Niacin—atherosclerosis	0.0028	0.00643	CcSEcCtD
Carbachol—Diarrhoea—Ezetimibe—atherosclerosis	0.00277	0.00636	CcSEcCtD
Carbachol—Body temperature increased—Pravastatin—atherosclerosis	0.00276	0.00633	CcSEcCtD
Carbachol—Abdominal pain—Pravastatin—atherosclerosis	0.00276	0.00633	CcSEcCtD
Carbachol—Dizziness—Lovastatin—atherosclerosis	0.00273	0.00626	CcSEcCtD
Carbachol—Dizziness—Ezetimibe—atherosclerosis	0.00268	0.00614	CcSEcCtD
Carbachol—Diarrhoea—Simvastatin—atherosclerosis	0.00264	0.00606	CcSEcCtD
Carbachol—Vomiting—Lovastatin—atherosclerosis	0.00263	0.00602	CcSEcCtD
Carbachol—Rash—Lovastatin—atherosclerosis	0.0026	0.00597	CcSEcCtD
Carbachol—Dermatitis—Lovastatin—atherosclerosis	0.0026	0.00597	CcSEcCtD
Carbachol—Headache—Lovastatin—atherosclerosis	0.00259	0.00594	CcSEcCtD
Carbachol—Vomiting—Ezetimibe—atherosclerosis	0.00258	0.00591	CcSEcCtD
Carbachol—Dizziness—Simvastatin—atherosclerosis	0.00255	0.00586	CcSEcCtD
Carbachol—Rash—Ezetimibe—atherosclerosis	0.00255	0.00586	CcSEcCtD
Carbachol—Dermatitis—Ezetimibe—atherosclerosis	0.00255	0.00585	CcSEcCtD
Carbachol—Headache—Ezetimibe—atherosclerosis	0.00254	0.00582	CcSEcCtD
Carbachol—Vomiting—Simvastatin—atherosclerosis	0.00246	0.00563	CcSEcCtD
Carbachol—Nausea—Lovastatin—atherosclerosis	0.00245	0.00563	CcSEcCtD
Carbachol—Rash—Simvastatin—atherosclerosis	0.00244	0.00559	CcSEcCtD
Carbachol—Dermatitis—Simvastatin—atherosclerosis	0.00243	0.00558	CcSEcCtD
Carbachol—Diarrhoea—Niacin—atherosclerosis	0.00243	0.00557	CcSEcCtD
Carbachol—Headache—Simvastatin—atherosclerosis	0.00242	0.00555	CcSEcCtD
Carbachol—Nausea—Ezetimibe—atherosclerosis	0.00241	0.00552	CcSEcCtD
Carbachol—Diarrhoea—Pravastatin—atherosclerosis	0.00239	0.00548	CcSEcCtD
Carbachol—Dizziness—Niacin—atherosclerosis	0.00235	0.00538	CcSEcCtD
Carbachol—Dizziness—Pravastatin—atherosclerosis	0.00231	0.0053	CcSEcCtD
Carbachol—Nausea—Simvastatin—atherosclerosis	0.00229	0.00526	CcSEcCtD
Carbachol—Vomiting—Niacin—atherosclerosis	0.00225	0.00517	CcSEcCtD
Carbachol—Rash—Niacin—atherosclerosis	0.00224	0.00513	CcSEcCtD
Carbachol—Dermatitis—Niacin—atherosclerosis	0.00223	0.00513	CcSEcCtD
Carbachol—Headache—Niacin—atherosclerosis	0.00222	0.0051	CcSEcCtD
Carbachol—Vomiting—Pravastatin—atherosclerosis	0.00222	0.00509	CcSEcCtD
Carbachol—Rash—Pravastatin—atherosclerosis	0.0022	0.00505	CcSEcCtD
Carbachol—Dermatitis—Pravastatin—atherosclerosis	0.0022	0.00505	CcSEcCtD
Carbachol—Headache—Pravastatin—atherosclerosis	0.00219	0.00502	CcSEcCtD
Carbachol—Nausea—Niacin—atherosclerosis	0.00211	0.00483	CcSEcCtD
Carbachol—Nausea—Pravastatin—atherosclerosis	0.00207	0.00476	CcSEcCtD
Carbachol—PLA2G4A—Signaling Pathways—EDN1—atherosclerosis	0.000131	0.000233	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000131	0.000232	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HMGCR—atherosclerosis	0.00013	0.000231	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AGT—atherosclerosis	0.00013	0.000231	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCL5—atherosclerosis	0.00013	0.000231	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—APOE—atherosclerosis	0.000128	0.000226	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—LPL—atherosclerosis	0.000127	0.000226	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CAV1—atherosclerosis	0.000126	0.000224	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—APOA1—atherosclerosis	0.000126	0.000224	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000126	0.000223	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000126	0.000223	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000125	0.000222	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000125	0.000222	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000125	0.000221	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000124	0.00022	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000124	0.00022	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000124	0.00022	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PRKCG—atherosclerosis	0.000124	0.000219	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000124	0.000219	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000123	0.000219	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000123	0.000218	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000122	0.000217	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000122	0.000216	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000122	0.000216	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000121	0.000214	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SPP1—atherosclerosis	0.000121	0.000214	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000121	0.000214	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.00012	0.000214	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CXCL8—atherosclerosis	0.00012	0.000213	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000119	0.000212	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000116	0.000206	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000116	0.000205	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000115	0.000205	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CG—atherosclerosis	0.000115	0.000204	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000114	0.000203	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000113	0.0002	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000112	0.000199	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PDGFB—atherosclerosis	0.000112	0.000198	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000111	0.000197	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PPARG—atherosclerosis	0.000111	0.000197	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000111	0.000196	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.00011	0.000196	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000109	0.000194	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000109	0.000194	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000109	0.000194	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000109	0.000193	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000109	0.000193	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—INS—atherosclerosis	0.000109	0.000193	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AGT—atherosclerosis	0.000109	0.000193	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000109	0.000193	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000109	0.000192	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—AKT1—atherosclerosis	0.000108	0.000192	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000108	0.000191	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000108	0.000191	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000108	0.000191	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000108	0.000191	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000108	0.000191	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—LEP—atherosclerosis	0.000107	0.000189	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—APOE—atherosclerosis	0.000107	0.000189	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000107	0.000189	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000107	0.000189	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000107	0.000189	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000107	0.000189	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000106	0.000188	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000106	0.000188	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000106	0.000188	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CAV1—atherosclerosis	0.000106	0.000187	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—APOA1—atherosclerosis	0.000106	0.000187	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000105	0.000187	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000105	0.000187	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000105	0.000187	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000102	0.000181	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000102	0.000181	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ESR1—atherosclerosis	0.000102	0.000181	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000101	0.000179	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—F2—atherosclerosis	0.000101	0.000178	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ALB—atherosclerosis	0.0001	0.000177	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HMOX1—atherosclerosis	9.97e-05	0.000177	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	9.8e-05	0.000174	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	9.77e-05	0.000173	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	9.67e-05	0.000171	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CG—atherosclerosis	9.63e-05	0.000171	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—NOS3—atherosclerosis	9.56e-05	0.000169	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOB—atherosclerosis	9.55e-05	0.000169	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KNG1—atherosclerosis	9.36e-05	0.000166	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KNG1—atherosclerosis	9.33e-05	0.000165	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	9.3e-05	0.000165	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GSTM1—atherosclerosis	9.29e-05	0.000165	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	9.27e-05	0.000164	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KNG1—atherosclerosis	9.24e-05	0.000164	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—MAPK3—atherosclerosis	9.22e-05	0.000164	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	9.18e-05	0.000163	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	9.13e-05	0.000162	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—LPL—atherosclerosis	9.12e-05	0.000162	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—INS—atherosclerosis	9.12e-05	0.000162	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	9.1e-05	0.000161	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PLG—atherosclerosis	9.07e-05	0.000161	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PLG—atherosclerosis	9.04e-05	0.00016	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	9.01e-05	0.00016	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCL2—atherosclerosis	8.97e-05	0.000159	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PLG—atherosclerosis	8.95e-05	0.000159	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPX1—atherosclerosis	8.9e-05	0.000158	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IGF1—atherosclerosis	8.82e-05	0.000156	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTGS2—atherosclerosis	8.75e-05	0.000155	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CD36—atherosclerosis	8.67e-05	0.000154	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	8.59e-05	0.000152	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	8.56e-05	0.000152	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	8.47e-05	0.00015	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SERPINE1—atherosclerosis	8.37e-05	0.000148	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP3—atherosclerosis	8.29e-05	0.000147	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP3—atherosclerosis	8.27e-05	0.000147	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF2—atherosclerosis	8.25e-05	0.000146	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF2—atherosclerosis	8.23e-05	0.000146	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MTHFR—atherosclerosis	8.21e-05	0.000146	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP3—atherosclerosis	8.18e-05	0.000145	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF2—atherosclerosis	8.15e-05	0.000144	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARA—atherosclerosis	8.06e-05	0.000143	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOB—atherosclerosis	8.01e-05	0.000142	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NOS3—atherosclerosis	8e-05	0.000142	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOB—atherosclerosis	7.99e-05	0.000142	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	7.95e-05	0.000141	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	7.92e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOB—atherosclerosis	7.91e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EDN1—atherosclerosis	7.89e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EDN1—atherosclerosis	7.86e-05	0.000139	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	7.84e-05	0.000139	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL5—atherosclerosis	7.83e-05	0.000139	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AGT—atherosclerosis	7.8e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL5—atherosclerosis	7.8e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EDN1—atherosclerosis	7.79e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL5—atherosclerosis	7.72e-05	0.000137	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LPL—atherosclerosis	7.65e-05	0.000136	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOE—atherosclerosis	7.65e-05	0.000136	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LPL—atherosclerosis	7.63e-05	0.000135	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CAV1—atherosclerosis	7.58e-05	0.000134	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOA1—atherosclerosis	7.56e-05	0.000134	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LPL—atherosclerosis	7.55e-05	0.000134	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	7.44e-05	0.000132	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	7.42e-05	0.000131	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	7.34e-05	0.00013	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SPP1—atherosclerosis	7.25e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SPP1—atherosclerosis	7.22e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	7.22e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	7.19e-05	0.000127	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SPP1—atherosclerosis	7.15e-05	0.000127	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	7.12e-05	0.000126	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL8—atherosclerosis	7.09e-05	0.000126	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CG—atherosclerosis	6.9e-05	0.000122	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—atherosclerosis	6.74e-05	0.00012	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	6.71e-05	0.000119	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	6.68e-05	0.000118	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARG—atherosclerosis	6.66e-05	0.000118	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	6.62e-05	0.000117	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGT—atherosclerosis	6.55e-05	0.000116	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—INS—atherosclerosis	6.53e-05	0.000116	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGT—atherosclerosis	6.53e-05	0.000116	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGT—atherosclerosis	6.46e-05	0.000115	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—atherosclerosis	6.41e-05	0.000114	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LEP—atherosclerosis	6.41e-05	0.000114	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOE—atherosclerosis	6.41e-05	0.000114	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LEP—atherosclerosis	6.39e-05	0.000113	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOE—atherosclerosis	6.39e-05	0.000113	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CAV1—atherosclerosis	6.35e-05	0.000113	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NFKB1—atherosclerosis	6.35e-05	0.000113	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOA1—atherosclerosis	6.34e-05	0.000112	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CAV1—atherosclerosis	6.33e-05	0.000112	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LEP—atherosclerosis	6.33e-05	0.000112	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOE—atherosclerosis	6.33e-05	0.000112	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOA1—atherosclerosis	6.32e-05	0.000112	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CAV1—atherosclerosis	6.27e-05	0.000111	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOA1—atherosclerosis	6.26e-05	0.000111	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK8—atherosclerosis	6.24e-05	0.000111	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—atherosclerosis	6.22e-05	0.00011	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ESR1—atherosclerosis	6.12e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ESR1—atherosclerosis	6.1e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—F2—atherosclerosis	6.05e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ESR1—atherosclerosis	6.04e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—F2—atherosclerosis	6.03e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ALB—atherosclerosis	5.99e-05	0.000106	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—F2—atherosclerosis	5.97e-05	0.000106	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.79e-05	0.000103	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	5.77e-05	0.000102	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—atherosclerosis	5.76e-05	0.000102	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NOS3—atherosclerosis	5.73e-05	0.000102	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	5.71e-05	0.000101	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—atherosclerosis	5.7e-05	0.000101	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	5.54e-05	9.83e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	5.53e-05	9.8e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—INS—atherosclerosis	5.48e-05	9.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	5.47e-05	9.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—INS—atherosclerosis	5.46e-05	9.68e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK3—atherosclerosis	5.45e-05	9.66e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—INS—atherosclerosis	5.41e-05	9.59e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL2—atherosclerosis	5.39e-05	9.56e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL2—atherosclerosis	5.37e-05	9.53e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL2—atherosclerosis	5.32e-05	9.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1—atherosclerosis	5.3e-05	9.39e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFB1—atherosclerosis	5.29e-05	9.37e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1—atherosclerosis	5.28e-05	9.36e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—atherosclerosis	5.24e-05	9.29e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1—atherosclerosis	5.23e-05	9.27e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	5.03e-05	8.92e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	5.02e-05	8.89e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.97e-05	8.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.81e-05	8.52e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOS3—atherosclerosis	4.79e-05	8.49e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.74e-05	8.41e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—atherosclerosis	4.4e-05	7.79e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	4.26e-05	7.56e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	4.25e-05	7.53e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	4.21e-05	7.46e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	4.12e-05	7.3e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	4.1e-05	7.28e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	4.06e-05	7.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—atherosclerosis	4.05e-05	7.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—atherosclerosis	4.04e-05	7.16e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—atherosclerosis	4e-05	7.09e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—atherosclerosis	3.98e-05	7.06e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.86e-05	6.83e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.84e-05	6.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.81e-05	6.76e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.81e-05	6.75e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.8e-05	6.74e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.77e-05	6.67e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.75e-05	6.65e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.74e-05	6.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	3.74e-05	6.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	3.73e-05	6.61e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.7e-05	6.56e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.69e-05	6.54e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—atherosclerosis	3.68e-05	6.51e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	3.46e-05	6.14e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	3.45e-05	6.12e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STAT3—atherosclerosis	3.43e-05	6.08e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	3.42e-05	6.06e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—atherosclerosis	3.42e-05	6.06e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—atherosclerosis	3.38e-05	6e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	3.27e-05	5.8e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	3.26e-05	5.79e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	3.23e-05	5.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	3.18e-05	5.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	3.17e-05	5.61e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	3.14e-05	5.56e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—atherosclerosis	2.63e-05	4.67e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.39e-05	4.24e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—atherosclerosis	2.39e-05	4.23e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.36e-05	4.19e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—atherosclerosis	2.21e-05	3.92e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—atherosclerosis	2.2e-05	3.9e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.18e-05	3.86e-05	CbGpPWpGaD
